clinical trial · NCT06817096
Efficacy and Safety of Nitazoxanide 600 Mg in the Outpatient Treatment of COVID-19 and Influenza
Azidus Brasil·phase3·not yet recruiting·n = 340
Covid 19InfluenzaNitazoxanide 600Mg Oral Tablet / placebo oral tablet
brief summary
2\. Participants will: * Take nitazoxanide 600mg (or placebo) orally twice daily for 7 days, for a total of 14 doses. * Visit the clinic on the 7th day of treatment for a check-up and safety tests. * Keep a diary of their symptoms and other medications used
started
Feb 1, 2025
primary completion
Dec 1, 2026
completion
Jun 1, 2027
last updated
Feb 10, 2025
official title
Phase 3, Multicenter, Parallel, Randomized, Single-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Nitazoxanide 600 Mg Administered Twice Daily, in the Outpatient Treatment of COVID-19 and Influenza
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol